ClinicalTrials.govpublic full text
Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
locally advanced esophageal squamous cell carcinoma, esophageal squamous cell carcinoma, neoadjuvant immunotherapy, pathological complete response, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 825031
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.